Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study
Purpose: IVM preceded by a prematuration step (capacitation [CAPA]-IVM) improves the acquisition of oocyte developmental competence and can enhance embryo quality. There is currently no follow-up data on babies born from CAPA-IVM. This study investigated developmental outcomes in children born after CAPA-IVM versus natural conception.
Methods: This prospective cohort study was conducted at a fertility clinic in Vietnam in August/September 2019. Children born after CAPA-IVM were propensity score-matched with those born after natural conception. All parents were asked to complete the Developmental Red Flags and Ages & Stages Third Edition (ASQ-3) questionnaires.
Results: A total of 46 parents (23 in each group) of 55 babies (31 CAPA-IVM and 24 natural conception) were included in the study. Baseline characteristics, including mother's age and body mass index, gestational age at delivery, and birth weight, were comparable. The mean age of children at the end of follow-up was 15 months. The overall proportion of children with any abnormal ASQ-3 score was 6.5% in the CAPA-IVM group and 20.8% in the natural conception group (p = 0.24). The proportion of children with a developmental red flag did not differ significantly between the CAPA-IVM and natural conception groups (9.7% vs. 4.2%; p = 0.80).
Conclusions: The use of CAPA-IVM did not have any significant impact on childhood physical and mental development compared with children born as a result of natural conception.
ASQ-3; Capacitation; Childhood development; In vitro fertilization; In vitro maturation; Red Flag sign.
Review The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia
[ Nikolaos P. Polyzos1,2,*, A.R. Neves 1,3, P. Drakopoulos 4,5, C. Spits5, B. Alvaro Mercadal6,7, S. Garcia1, P.Q.M. Ma8, L.H. Le8, M.T. Ho8, J. Mertens5, D. Stoop2, H. Tournaye4,5,9, and N.L. Vuong 10 ]
Does the presence of single nucleotide polymorphisms (SNPs) in the FSH receptor gene (FSHR) a...
Review Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
[ V. N. A. Ho1, T. D. Pham1, A. H. Le1, T. M. Ho1 and L. N. Vuong1,2* ]
In vitro maturation (IVM) has some advantages over conventional in vitro fertilization (IVF), particul...
Review SARS-CoV-2 and Assisted Reproductive Technology Practice An Asia Paciﬁc Initiative on Reproduction (ASPIRE) Position Paper
[ Budi Wiweko 1, Tuong M. Ho 2, Rong Li 3, Tin-Chiu Li 4, Chii-Ruey Tzeng 5, Gab Kovacs 6, Atsushi Tanaka 7, Jung Ryeol Lee 8, Hrishikesh Pai 9, Haroon Latif Khan 10, on behalf of the Asia Pacific Initiative on Reproduction (ASPIRE) ]
Background: Asia Pacific Initiative on Repr...
Review Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients
[ Sandro C Esteves1, Hakan Yarali2,3, Lan N Vuong4,5,6, José F Carvalho7, İrem Y Özbek2, Mehtap Polat2, Ho L Le4,5, Toan D Pham4,5, Tuong M Ho4,5 ]
Review Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35–42 years with a body weight ≥50 kg: a randomized controlled trial
[ N.L. Vuong1,2,*, D.T. Pham2, H.T. Phung2, H.N. Giang2, G.B. Huynh2, T.T.L. Nguyen2, and M.T. Ho2,3 ]
Is corifollitropin alfa 150 μg equivalent to follitropin beta 300 IU/day for controlled ovarian...